CU20150017A7 - PHARMACEUTICAL COMPOSITIONS OBTAINED FROM ALTERNANTHERASESSILIS (L) R. Br. FOR THE TREATMENT OF PSORIASIS AND ITS PREPARATION PROCEDURE - Google Patents

PHARMACEUTICAL COMPOSITIONS OBTAINED FROM ALTERNANTHERASESSILIS (L) R. Br. FOR THE TREATMENT OF PSORIASIS AND ITS PREPARATION PROCEDURE

Info

Publication number
CU20150017A7
CU20150017A7 CUP2015000017A CU20150017A CU20150017A7 CU 20150017 A7 CU20150017 A7 CU 20150017A7 CU P2015000017 A CUP2015000017 A CU P2015000017A CU 20150017 A CU20150017 A CU 20150017A CU 20150017 A7 CU20150017 A7 CU 20150017A7
Authority
CU
Cuba
Prior art keywords
pharmaceutical compositions
psoriasis
alternantherasessilis
treatment
secondary metabolites
Prior art date
Application number
CUP2015000017A
Other languages
Spanish (es)
Other versions
CU24276B1 (en
Inventor
Olivet Eva Salas
Cuéllar Armando Cuéllar
Original Assignee
Inst De Farmacia Y Alimentos De La Universidad De La Habana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst De Farmacia Y Alimentos De La Universidad De La Habana filed Critical Inst De Farmacia Y Alimentos De La Universidad De La Habana
Priority to CUP2015000017A priority Critical patent/CU24276B1/en
Publication of CU20150017A7 publication Critical patent/CU20150017A7/en
Publication of CU24276B1 publication Critical patent/CU24276B1/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

Se lleva a cabo un Procedimiento de fraccionamiento para la extracción y caracterización de metabolitos secundarios de la planta Alternanthera Sessilis (L).R.Br. previo al proceso de elaboración de las composiciones farmacéuticas jarabe, gel de baño, crema, champú y encapsulación del material vegetal seco y micronizado en un molino de cuchilla y molino coloidal transformándose en un polvo de tamaño de partículas de 120 a 140 µm que es envasado posteriormente en cápsulas de gelatina 0.01-0.5 conteniendo 300 a 800 mg de polvo cada una, cuyo principio activo vital para tratar la Psoriasis son los metabolitos secundarios, capacidad antioxidante, propiedad nutricional y oligoelementos de la planta en cuestión que potencian el metabolismo y coadyuva a mantener el sistema inmune saludable.A fractionation procedure is carried out for the extraction and characterization of secondary metabolites of the Alternanthera Sessilis (L) .R.Br. prior to the preparation process of the pharmaceutical compositions syrup, bath gel, cream, shampoo and encapsulation of the dried and micronized plant material in a knife mill and colloid mill becoming a particle size powder of 120 to 140 µm which is packaged subsequently in 0.01-0.5 gelatin capsules containing 300 to 800 mg of powder each, whose vital active ingredient to treat Psoriasis are the secondary metabolites, antioxidant capacity, nutritional property and trace elements of the plant in question that enhance the metabolism and contribute to keep the immune system healthy.

CUP2015000017A 2015-02-26 2015-02-26 PHARMACEUTICAL COMPOSITIONS OBTAINED FROM ALTERNANTHERA SESSILIS (L) R.BR. FOR THE TREATMENT OF PSORIASIS AND ITS PREPARATION PROCEDURE CU24276B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CUP2015000017A CU24276B1 (en) 2015-02-26 2015-02-26 PHARMACEUTICAL COMPOSITIONS OBTAINED FROM ALTERNANTHERA SESSILIS (L) R.BR. FOR THE TREATMENT OF PSORIASIS AND ITS PREPARATION PROCEDURE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CUP2015000017A CU24276B1 (en) 2015-02-26 2015-02-26 PHARMACEUTICAL COMPOSITIONS OBTAINED FROM ALTERNANTHERA SESSILIS (L) R.BR. FOR THE TREATMENT OF PSORIASIS AND ITS PREPARATION PROCEDURE

Publications (2)

Publication Number Publication Date
CU20150017A7 true CU20150017A7 (en) 2016-10-28
CU24276B1 CU24276B1 (en) 2017-10-05

Family

ID=57219584

Family Applications (1)

Application Number Title Priority Date Filing Date
CUP2015000017A CU24276B1 (en) 2015-02-26 2015-02-26 PHARMACEUTICAL COMPOSITIONS OBTAINED FROM ALTERNANTHERA SESSILIS (L) R.BR. FOR THE TREATMENT OF PSORIASIS AND ITS PREPARATION PROCEDURE

Country Status (1)

Country Link
CU (1) CU24276B1 (en)

Also Published As

Publication number Publication date
CU24276B1 (en) 2017-10-05

Similar Documents

Publication Publication Date Title
He et al. Research progress on the health function of tea oil
CU20180002A7 (en) COCOA PRODUCTS BASED ON NON-FERMENTED COCOA BEANS AND METHODS FOR THE PREPARATION OF THEM
MX389324B (en) MULTI-PHASE SOFT GEL CAPSULES, APPARATUS AND METHOD THEREOF.
CU24617B1 (en) METHODS FOR THE PROCESSING OF COCOA FRUITS AND METHOD FOR THE MANUFACTURE OF CHOCOLATE OR CHOCOLATE-LIKE PRODUCTS
MX385569B (en) PHYTOCOMPLEXES THAT EXHIBIT MULTIPLE, SYNERGISTIC ANTIOXIDANT ACTIVITIES, USEFUL IN FOODS, FOOD SUPPLEMENTS, COSMETICS AND PHARMACEUTICAL PREPARATIONS.
WO2015016822A3 (en) Solid dietary compositions for ruminants and methods of making and using the same
WO2016190683A8 (en) Composition for preventing and treating muscle diseases or improving muscular function, containing platycodon grandiflorum extract
MX2023002137A (en) Formulations containing pomegranate seed oil, rosa canina fruit oil and inula viscosa oleoresin or extract.
NZ741022A (en) Flavonoid compositions and methods of use
MX387386B (en) PET FEEDING SYSTEM.
RU2012102815A (en) Means for stimulating the synthesis of heat shock proteins in cells of humans and animals, beauty products for stimulation of reparative processes, cosmetics TO REDUCE SIDE EFFECTS OF AGGRESSIVE beauty treatments, dietary supplements, food products, process reduce the side effects of cosmetic procedures AGGRESSIVE
JP2015508748A5 (en)
KR102093006B1 (en) Production of MACA Extracts with Optimized Extraction Methods
CU24276B1 (en) PHARMACEUTICAL COMPOSITIONS OBTAINED FROM ALTERNANTHERA SESSILIS (L) R.BR. FOR THE TREATMENT OF PSORIASIS AND ITS PREPARATION PROCEDURE
MX351668B (en) Activated, micronized zeolite, method for activating and micronizing same and use thereof as a carrier in pharmaceutical preparations and dietary supplements.
HRP20190676T1 (en) Composition for the prevention or treatment of polycystic ovary syndrome and its related symptoms
CO2021006414A2 (en) Method and device for drying plant material
PE20170199A1 (en) PHARMACEUTICAL COMPOSITION TO PREVENT AND TREAT SENILE DEMENTIA AND ITS METHOD OF PREPARATION
PH12019500024A1 (en) Pharmaceutical compositions
Saleem et al. Protective effects of mentha spicata aqueous extract against ifosfamide induced chromosomal aberrations and sperm abnormalities in male albino mice
WO2016114621A3 (en) Composition for prevention or treatment of metabolic bone diseases comprising combined extract of schisandra chinesis, eucommiae cortex and lycium chinense as active ingredient
ES2645254A1 (en) Procedure for the preparation of an antioxidant nutritional compound without fructose processed from the fruit of the granada, and composed obtained from it (Machine-translation by Google Translate, not legally binding)
CN103169082A (en) Hard garlic oil capsule and preparation method thereof
Evans et al. Natural product inhibitors of acetyl-lysine erasers in the prevention and treatment of heart failure
Nema et al. Food Bioactive Compounds: Pharmacology and Advancement in Analysis